0.70Open0.70Pre Close0 Volume140 Open Interest5.00Strike Price0.00Turnover268.84%IV38.04%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type-0.2012Delta0.0636Gamma9.91Leverage Ratio-0.0304Theta-0.0011Rho-1.99Eff Leverage0.0046Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet